20000 JAN strike 25 CALLS= OI an investor sells 10K Jan 15 puts to buy 10K Jan 25 - 40 call spreads, paying 49c for the package, and tied to 500K shares. The spread trades 16000X today and adds to 4.5K opened yesterday. The position expresses confidence that shares will hold $15 (or not fall more than 38.5%) and targets a 64% rally to $40 or better through early-2020. August 2018 52-week high is $40.94
In the near term, our priorities are clear; successfully complete ORION-9, 10 and 11 trials, to release top line data in the third quarter and to file an NDA and MAA with the U.S. and EU regulatory authorities, respectively. The countdown to Phase III results has begun. I'm passionate about inclisiran and maximizing the true value of this next generation therapy in cardiovascular medicine. I come to The Medicines Company with significant experience in cardiovascular medicine through building brands like Vytorin, Zetia and Zocor, and I have to say that inclisiran is one of the most promising medicines I have ever encountered.